Drugs Online |
 |
 | ||
|
REVOCON Nitoman |
|
| ||
Drugs Online » Prescription Drugs 14 » REVOCON Nitoman Tetrabenazine is a drug for the symptomatical treatment of hyperkinetic movement disorder and is marketed under the trade names Nitoman in Canada and Xenazine in New Zealand and some parts of Europe and is also available in the USA as an orphan drug. Tetrabenazine is used as a treatment but not a cure for hyperkinetic disorders[2] such as:Huntington's Disease - specificially the chorea associated with it Tourette's Syndrome and other tic disorders Tardive dyskinesia a serious and sometimes irreversible side effect of long-term use of many antipsychotics mainly typical antipsychotics Hemiballismus spontaneous flinging limb movements due to subthalamic nucleus damage Buy REVOCON Nitoman and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About REVOCON Nitoman: Product Type: Prescription Drugs 14 REVOCON ( Nitoman/Xenamine GENERIC Tetrabenazine ) REVOCON (Nitoman/Xenamine GENERIC Tetrabenazine) Nitoman/Xenamine GENERIC Tetrabenazine 25 mg Nitoman/Xenamine GENERIC Tetrabenazine REVOCON
View more Prescription Drugs 14 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
